1. Advice for avoiding terlipressin-related respiratory failure and sepsis

   News item 08 October 2022 Pages: 1 - 1

2. Alectinib-related haemolytic anaemia

   News item 08 October 2022 Pages: 2 - 2

3. Antica Ocean Citron Hand Sanitizer Gel recalled due to benzene

   News item 08 October 2022 Pages: 3 - 3

4. Batch of Sandimmun Oral Solution recalled in UK due to crystals

   News item 08 October 2022 Pages: 4 - 4

5. COVID-19 vaccination may trigger tattoo skin reactions

   News item 08 October 2022 Pages: 5 - 5

6. PRAC meeting highlights 26-29 September 2022

   News item 08 October 2022 Pages: 6 - 6

7. Switching long-acting methylphenidate formulations requires caution

   News item 08 October 2022 Pages: 7 - 7

8. Third-line indication for rucaparib withdrawn due to reduced survival

   News item 08 October 2022 Pages: 8 - 8

9. Acute diabetes complications not increased by CoronaVac or BNT162b2

   Clinical study 08 October 2022 Pages: 9 - 9

10. Depression increases adjuvant chemotherapy-related myelosuppression

    Clinical study 08 October 2022 Pages: 10 - 10

11. Medication administrative errors in the neonatal ICU

    Clinical study 08 October 2022 Pages: 11 - 11

12. Reviewing evidence of kidney effects of psychotropic drugs

    Clinical study 08 October 2022 Pages: 12 - 12

13. Other adverse reaction research

    News item 08 October 2022 Pages: 13 - 13

14. Aceclofenac/nimesulide/paracetamol

    Case report 08 October 2022 Pages: 14 - 14

15. Acetylcholine

    Case report 08 October 2022 Pages: 15 - 15

16. Acetylcysteine/paracetamol overdose

    Case report 08 October 2022 Pages: 16 - 16

17. Acitretin/immunosuppressants

    Case report 08 October 2022 Pages: 17 - 17

18. Acotiamide/esomeprazole

    Case report 08 October 2022 Pages: 18 - 18

19. Ad26.COV2-S vaccine

    Case report 08 October 2022 Pages: 19 - 19

20. Ad26.cov2-s/elasomeran

    Case report 08 October 2022 Pages: 20 - 20

21. Adalimumab

    Case report 08 October 2022 Pages: 21 - 21

22. Adalimumab/etanercept

    Case report 08 October 2022 Pages: 22 - 22

23. Adalimumab/infliximab

    Case report 08 October 2022 Pages: 23 - 23

24. Adalimumab/methotrexate

    Case report 08 October 2022 Pages: 24 - 24

25. Aflibercept

    Case report 08 October 2022 Pages: 25 - 25

26. Albumin-human/octreotide

    Case report 08 October 2022 Pages: 26 - 26

27. Alcohol/picibanil

    Case report 08 October 2022 Pages: 27 - 27

28. Alectinib

    Case report 08 October 2022 Pages: 28 - 28

29. Alemtuzumab

    Case report 08 October 2022 Pages: 29 - 29

30. Alendronic-acid

    Case report 08 October 2022 Pages: 30 - 30

31. Allo-316/foscarnet

    Case report 08 October 2022 Pages: 31 - 31

32. Allopurinol

    Case report 08 October 2022 Pages: 32 - 32

33. Allopurinol

    Case report 08 October 2022 Pages: 33 - 33

34. Alteplase

    Case report 08 October 2022 Pages: 34 - 34

35. Amiodarone

    Case report 08 October 2022 Pages: 35 - 35

36. Amiodarone

    Case report 08 October 2022 Pages: 36 - 36

37. Amitriptyline/oxycodone/pregabalin

    Case report 08 October 2022 Pages: 37 - 37

38. Amphotericin-B

    Case report 08 October 2022 Pages: 38 - 38

39. Amphotericin-B

    Case report 08 October 2022 Pages: 39 - 39

40. Amphotericin-b

    Case report 08 October 2022 Pages: 40 - 40

41. Amphotericin-B-liposomal/caspofungin/micafungin

    Case report 08 October 2022 Pages: 41 - 41

42. Anakinra/cotrimoxazole/immune-globulin

    Case report 08 October 2022 Pages: 42 - 42

43. Anti-infectives/dexamethasone/omeprazole

    Case report 08 October 2022 Pages: 43 - 43

44. Antianaemics/antineoplastics/antiplatelets

    Case report 08 October 2022 Pages: 44 - 44

45. Antibacterials

    Case report 08 October 2022 Pages: 45 - 45

46. Antibacterials/antituberculars

    Case report 08 October 2022 Pages: 46 - 46

47. Antibacterials/antituberculars/Dexamethasone

    Case report 08 October 2022 Pages: 47 - 47

48. Antibacterials/azithromycin/ceftriaxone

    Case report 08 October 2022 Pages: 48 - 48

49. Antibacterials/sevelamer/warfarin

    Case report 08 October 2022 Pages: 49 - 49

50. Antibacterials/sulfasalazine

    Case report 08 October 2022 Pages: 50 - 50